NCM·Healthcare·$549M·#132 / 520 in Healthcare
TOI The Oncology Institute, Inc.
60SOLID
CATEGORY BREAKDOWN
GROWTH44
QUALITY33
STABILITY72
VALUATION100
GOVERNANCE77
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+27.8%
44
> 50% strong
Gross Margin
Revenue retained after direct costs
15.2%
20
> 50% strong
Cash Runway
Months of cash at current burn rate
16 months
58
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-659.6%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.0x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
21
51
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
18.2%
81
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+5.2%
69
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE TOI WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when TOI's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.